AstraZeneca PLC notes improved PFS with Tagrisso + Orpathys in 1L EGFRm lung
AstraZeneca PLC said Tagrisso plus Orpathys improved PFS in first-line EGFRm lung cancer.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.